The Group has extensive experience of advising on clinical drug trials. Our lawyers have advised on drug trial agreements and the related protocols and where called upon to do so have drafted such documentation. We have considerable experience on advising on the issues that arise from clinical drug trials, such as the ethical obligations to obtain informed consent from the subjects of the trial.
Where relevant, the input of lawyers in the commercial team is available to advise, in particular, on the financial aspects of drug trials including obtaining indemnities from the commercial body sponsoring the trials, the intellectual property implications for the parties to the agreement and the likely enforceability of indemnities.
Our experience covers trials in all areas including psychiatric drugs, gynaecological drugs, drugs for the control of epilepsy and drugs intended for the treatment of paediatric patients. We also advise on the risk management aspects of clinical pathways and protocols.